Vancomycin-Resistant Enterococci: Approach to Treatment and Control

Ardino R.C. , Murray B.E. Enterococcus: antimicrobial resistance. In: Mandell G.L. , Douglas R.G. Jr , Bennett J.E. , eds. Principles and Practice of Infectious Diseases. 3rd ed. New York, NY: Churchill Livingstone; 1990. Update Vol 2, No 4.

Moellering R.C. Jr . Enterococcus species, streptococcus bovis, and leuconostoc species. In: Mandell G.L. , Bennett J.E. , Dolin R. , eds. Principles and Practice of Infectious Diseases. 4th ed. New York, NY: Churchill Livingstone; 1995: 1826–1835.

Steigbigel N.H. Macrolides and clindamycin. In: Mandel G.L. , Bennett J.E. , Dolin R. , eds. Principles and Practice of Infectious Diseases. 4th ed. New York, NY: Churchill Livingstone; 1995: 334–346.

Vancomycin-resistant enterococci. Premier. 1994: 1–6.

Centers for Disease Control and Prevention. Nosocomial enterococcus resistant to vancomycin<United States, 1989–1993. MMWR Morb Mortal Wkly Rep. 1993; 42: 597–599.

Shlaes D.M. Vancomycin-resistant bacteria. Infect Control Hosp Epidemiol. 1992; 13: 193–194.

Clark N.C. , Cooksey R.C. , Hill B.C. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother. 1993; 37: 2311–2317.

Thauvin C. , Eliopoulos G.M. , Willey S. Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats. Antimicrob Agents Chemother. 1987; 31: 139–143.

Landman D. , Mobarakai N.K. , Quale J.M. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin. Antimicrob Agents Chemother. 1993; 37: 1904–1908.

Shlaes D.M. , Etter L. , Gutmann L. Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicin. Antimicrob Agents Chemother. 1991; 35: 776–779.

Leclercq R. , Bingen E. , Su Q.H. Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci. Antimicrob Agents Chemother. 1991; 35: 92–98.

Caron F. , Carbon C. , Gutmann L. Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium. J Infect Dis. 1991; 164: 888–893.

Fraimow H.S. , Venuti E. Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 1992; 36: 1563–1566.

Cercenado E. , Eliopoulos G.M. , Wennersten C.B. Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci. Antimicrob Agents Chemother. 1992; 36: 2201–2203.

Livornese L.L. Jr , Dias S. , Samel C. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med. 1992; 117: 112–116.

Charnow J.A. Studies expand fund of epidemiologic data on VRE. Infect Dis News. 1994; Oct: 1–5.

Tablan O.C. , Tenover F.C. , Martone W.J. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep. 1995; 44(RR-12): 1–13.

Recommendations for preventing the spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1995; 16: 105–113.

Broome C.V. Preventing the spread of vancomycin resistance: a report from the Hospital Infection Control Practices Advisory Committee prepared by the Subcommittee on Prevention and Control of Antimicrobial-Resistant Microorganisms in Hospitals. Federal Register. 1994; 59: 25758–25763.

Hayden M.K. , Harris A.A. Confronting antibiotic resistance in enterococcal infections. Contemp Intern Med. 1994; 6: 7–17.

Goldman D.A. , Weinstein R.A. , Wenzel R.P. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. JAMA. 1996; 275: 234–240.